Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	70.01	-2.59	-8.65
Graham Fair Price	-11.69	12.27	13.89
PEG	23.26	-0.01	0.01
Price/Book	79.35	1.09	0.61
Price/Cash Flow	-100.00	-2.20	0.00
Prices/Earnings	36.79	-0.62	-0.98
Price/Sales	-70.97	32.83	113.08
Price/FCF	-100.00	-2.20	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-55.11	0.45	1.00
Operating Margin	50.43	-14.47	-29.18
ROA	-100.00	-0.22	0.00
ROE	-0.16	-0.44	-183.72
ROIC	-0.16	-0.31	-98.78
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.55	-1.14	108.84
EPS QOQ	0.97	-0.50	-48.72
FCF QOQ	1.00	0.00	inf
Revenue QOQ	0.42	3.32	695.61
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	514.41	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.30	100.00
Quick Ratio	0.00	1.06	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	7.43	3.90	-47.57
Cash	5.11	1.59	-68.82
Capex	0.00	0.02	100.00
Free Cash Flow	0.00	-1.93	-100.00
Revenue	0.04	0.13	223.92
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	1.06	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.59	-0.24	94.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating